Related Experiment Video
Updated: Mar 7, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Altered Plasma MicroRNA Expression in Patients with Mitral Chordae Tendineae Rupture
Mehmet Bulent Vatan1, Aysel Kalaycı Yigin2, Ramazan Akdemir3
1Department of Cardiology, Sakarya University School of Medicine, Sakarya, Turkey. Electronic correspondence: bulentvatan@hotmail.com.
Background:
Mitral chordae tendineae rupture (MCTR) is a progressive disorder which leads to severe mitral regurgitation. Despite its importance, the precise pathogenetic mechanism of MCTR remains unclear. The study aim was to investigate the expression profile of circulating microRNAs (miRNAs) as being potentially involved in the development of MCTR.
Methods:
Twenty-one patients with 'primary' MCTR, and 30 age- and gender-matched controls, were enrolled in the study. Comparisons were made between the expression levels of circulating miRNAs in MCTR patients and controls. Four target gene databases were used to predict target genes and pathways of differentially expressed miRNAs.
Results:
Compared to controls, the expression of 22 miRNAs (hsa-miR-106b-5p, hsa-miR-126-3p, hsa-miR-150-5p, hsa-miR-17-5p, hsa-miR-195-5p, hsa-miR-19a-3p, hsa-miR-19b-3p, hsa-miR-20a-5p, hsa-miR-21-5p, hsa-miR-222-3p, hsa-miR-223-3p, hsa-miR-23a-3p, hsa-miR-25-3p, hsa-miR-92a-3p, hsa-miR-93-5p, hsa-miR-26b-5p, hsa-miR-30e-5p, hsa-miR-373-3p, hsa-miR-15b-5p, hsa-miR-16-5p, hsa-miR-191-5p, hsa-miR-26a-5p) were significantly down-regulated in the MCTR group. Bioinformatic analysis indicated that the following potential miRNA targets and pathways are commonly related to the development of MCTR: MMPs, TIMP-2,TGFBR2, VEGFA, PIK3R2, NRAS, PPP3CA, PPP3R1, PTGS 2 were predicted as putative targets of 13 of these miRNAs.
Conclusions:
The present study is the first to describe altered miRNA expression in patients with MCTR. Bioinformatic analysis has revealed that target genes involved in MCTR development were regulated by miRNAs.
Insights
This study found that 22 specific microRNAs (miRNAs) are down-regulated in patients with mitral chordae tendineae rupture (MCTR). These miRNAs are involved in pathways crucial for MCTR development, offering new insights into this severe heart condition.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Mitral chordae tendineae rupture (MCTR) is a progressive disorder causing severe mitral regurgitation.
- The exact pathogenetic mechanisms underlying MCTR remain largely unknown.
- Investigating circulating microRNAs (miRNAs) offers a potential avenue to understand MCTR development.
Purpose of the Study:
- To investigate the expression profile of circulating miRNAs in patients with primary MCTR.
- To identify specific miRNAs potentially involved in the pathogenesis of MCTR.
- To explore the target genes and pathways associated with differentially expressed miRNAs in MCTR.
Main Methods:
- A case-control study involving 21 patients with primary MCTR and 30 matched controls.
- Comparison of circulating miRNA expression levels between MCTR patients and controls.
- Bioinformatic analysis using four target gene databases to predict miRNA targets and pathways.
Main Results:
- Twenty-two specific miRNAs were significantly down-regulated in MCTR patients compared to controls.
- Key miRNAs identified include miR-106b-5p, miR-126-3p, miR-150-5p, and others.
- Bioinformatic analysis predicted that MMPs, TIMP-2, TGFBR2, VEGFA, and other genes/pathways are targeted by these miRNAs.
Conclusions:
- This study is the first to report altered miRNA expression in MCTR patients.
- Circulating miRNAs play a regulatory role in the development of MCTR.
- The findings provide a foundation for understanding MCTR pathogenesis and potential therapeutic targets.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management

